CYP19A1 and breast cancer: In addition to the PCP4/PEP19 functions inhibiting apoptosis and increasing migratory and invasive activities [13, 16], the present study indicates a new function, by which PCP4/PEP19 would enhance breast cancer cell proliferation by promoting paracrine estrogen-signaling via aromatase expression.